

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.73506016 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.73506016 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.73506016 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.73506016 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.73506016 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.73506016 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.90272494 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 6.74295548 |
| 9 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 6.38782771 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.75827958 |
| 11 | respiratory burst (GO:0045730) | 5.58055895 |
| 12 | response to host immune response (GO:0052572) | 5.46582000 |
| 13 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.46582000 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 5.36751290 |
| 15 | detection of bacterium (GO:0016045) | 5.05228550 |
| 16 | response to peptidoglycan (GO:0032494) | 5.01175470 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.99795670 |
| 18 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.99725024 |
| 19 | response to host (GO:0075136) | 4.99725024 |
| 20 | response to host defenses (GO:0052200) | 4.99725024 |
| 21 | cellular extravasation (GO:0045123) | 4.96062836 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 4.95341922 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.93132173 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.92194002 |
| 25 | detection of external biotic stimulus (GO:0098581) | 4.70067583 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 4.65919380 |
| 27 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.65034616 |
| 28 | neutrophil activation (GO:0042119) | 4.64590561 |
| 29 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.57250445 |
| 30 | granulocyte activation (GO:0036230) | 4.45646248 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 4.40101191 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 4.35173212 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.32615693 |
| 34 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.29730511 |
| 35 | detection of biotic stimulus (GO:0009595) | 4.27583480 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.22329730 |
| 37 | negative regulation of mast cell activation (GO:0033004) | 4.21159240 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19138446 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 4.13211792 |
| 40 | microglial cell activation (GO:0001774) | 4.13029100 |
| 41 | regulation of leukocyte degranulation (GO:0043300) | 4.08676004 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.96639782 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.95760973 |
| 44 | leukocyte aggregation (GO:0070486) | 3.95393357 |
| 45 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.91046939 |
| 46 | negative regulation of phagocytosis (GO:0050765) | 3.89578054 |
| 47 | * neutrophil mediated immunity (GO:0002446) | 3.88352330 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.87322044 |
| 49 | pinocytosis (GO:0006907) | 3.85957455 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.84005080 |
| 51 | response to fungus (GO:0009620) | 3.83662321 |
| 52 | macrophage activation (GO:0042116) | 3.74497249 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69259529 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.69259529 |
| 55 | * regulation of mast cell activation (GO:0033003) | 3.66692694 |
| 56 | neutrophil chemotaxis (GO:0030593) | 3.65441781 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57422136 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.55549971 |
| 59 | positive regulation of mast cell degranulation (GO:0043306) | 3.55162501 |
| 60 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.55162501 |
| 61 | neutrophil migration (GO:1990266) | 3.55091312 |
| 62 | B cell mediated immunity (GO:0019724) | 3.53064410 |
| 63 | defense response to fungus (GO:0050832) | 3.49509877 |
| 64 | mannose metabolic process (GO:0006013) | 3.47714225 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.42457796 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41708451 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39168997 |
| 68 | macrophage differentiation (GO:0030225) | 3.38898898 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.38809935 |
| 70 | positive regulation of leukocyte degranulation (GO:0043302) | 3.38387969 |
| 71 | regulation of tolerance induction (GO:0002643) | 3.36814461 |
| 72 | regulation of regulated secretory pathway (GO:1903305) | 3.34725490 |
| 73 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.32940253 |
| 74 | leukocyte mediated cytotoxicity (GO:0001909) | 3.32504989 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.30054893 |
| 76 | leukocyte degranulation (GO:0043299) | 3.28972676 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 3.28444891 |
| 78 | phagosome maturation (GO:0090382) | 3.27576984 |
| 79 | positive regulation of B cell differentiation (GO:0045579) | 3.23605235 |
| 80 | reactive oxygen species biosynthetic process (GO:1903409) | 3.22835894 |
| 81 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.21526632 |
| 82 | response to interleukin-15 (GO:0070672) | 3.21158457 |
| 83 | positive regulation of interferon-beta production (GO:0032728) | 3.21101344 |
| 84 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20794321 |
| 85 | leukotriene metabolic process (GO:0006691) | 3.17695570 |
| 86 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.16155334 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15596775 |
| 88 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.14031543 |
| 89 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.14031543 |
| 90 | * positive regulation of mast cell activation (GO:0033005) | 3.10734475 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10257476 |
| 92 | granulocyte chemotaxis (GO:0071621) | 3.09267292 |
| 93 | actin nucleation (GO:0045010) | 3.08618264 |
| 94 | negative regulation of interleukin-17 production (GO:0032700) | 3.08612542 |
| 95 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07255452 |
| 96 | myeloid leukocyte activation (GO:0002274) | 3.04590600 |
| 97 | germinal center formation (GO:0002467) | 3.02547242 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01469705 |
| 99 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.01235698 |
| 100 | type I interferon signaling pathway (GO:0060337) | 3.00678499 |
| 101 | cellular response to type I interferon (GO:0071357) | 3.00678499 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 3.00388265 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99595175 |
| 104 | regulation of B cell differentiation (GO:0045577) | 2.99572338 |
| 105 | granulocyte migration (GO:0097530) | 2.99314634 |
| 106 | superoxide anion generation (GO:0042554) | 2.98510438 |
| 107 | response to type I interferon (GO:0034340) | 2.97652576 |
| 108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95768178 |
| 109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.95768178 |
| 110 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.95558617 |
| 111 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.95293668 |
| 112 | negative regulation of interleukin-1 production (GO:0032692) | 2.94285136 |
| 113 | regulation of cholesterol storage (GO:0010885) | 2.93570110 |
| 114 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.92513840 |
| 115 | regulation of phagocytosis (GO:0050764) | 2.90110893 |
| 116 | detection of molecule of bacterial origin (GO:0032490) | 2.89849105 |
| 117 | positive thymic T cell selection (GO:0045059) | 2.88656277 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87878846 |
| 119 | hyaluronan catabolic process (GO:0030214) | 2.86257073 |
| 120 | regulation of macrophage cytokine production (GO:0010935) | 2.85741986 |
| 121 | T-helper 1 type immune response (GO:0042088) | 2.85734053 |
| 122 | dendritic cell migration (GO:0036336) | 2.85104907 |
| 123 | I-kappaB phosphorylation (GO:0007252) | 2.84118644 |
| 124 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.83841192 |
| 125 | cellular response to interleukin-15 (GO:0071350) | 2.83762311 |
| 126 | negative regulation of type 2 immune response (GO:0002829) | 2.83214481 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.83202310 |
| 128 | detection of other organism (GO:0098543) | 2.82349540 |
| 129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81984186 |
| 130 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.81597852 |
| 131 | negative regulation of interleukin-6 production (GO:0032715) | 2.80661058 |
| 132 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.78170678 |
| 133 | defense response to protozoan (GO:0042832) | 2.78161075 |
| 134 | low-density lipoprotein particle clearance (GO:0034383) | 2.77356883 |
| 135 | lymphocyte chemotaxis (GO:0048247) | 2.76471288 |
| 136 | * myeloid leukocyte mediated immunity (GO:0002444) | 2.75612578 |
| 137 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.74664734 |
| 138 | natural killer cell mediated immunity (GO:0002228) | 2.74664734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.42571141 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.53597682 |
| 3 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.44052977 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.43517524 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.43107327 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.09263543 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.03179457 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.95788875 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.75641377 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.14519592 |
| 11 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.02995379 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.70530001 |
| 13 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.67852672 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.66743226 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.66559791 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.50680722 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48486197 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45780178 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44305811 |
| 20 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.25449795 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21209238 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.19882636 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19171659 |
| 24 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11615139 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07276186 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04699028 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.99826156 |
| 28 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.99052274 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94572630 |
| 30 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91931161 |
| 31 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.89036572 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82799315 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.80601023 |
| 34 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79991758 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73679871 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.72587122 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70993774 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69757246 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64767130 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63596042 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57964752 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57041130 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56024707 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55795253 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52938564 |
| 46 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50546988 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48974476 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.46164291 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46066528 |
| 50 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45788821 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44022635 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.43693373 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39786509 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38328933 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37759269 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37687243 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.37528733 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34187006 |
| 59 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34095077 |
| 60 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31890703 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30636096 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28279669 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24731639 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23767071 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21980291 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21337460 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20001522 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19535963 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19264521 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19174369 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16340003 |
| 72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11800096 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11675672 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11537141 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09289227 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06578040 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06244878 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06151337 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05511958 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04014801 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02648853 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01756558 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01564571 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01166426 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01036579 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97865961 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97643441 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97242510 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97122830 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95577556 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 0.95531861 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93433410 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91705309 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90329732 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90303438 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89721993 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88411738 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84275981 |
| 99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80270083 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79782332 |
| 101 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79686719 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74501598 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74447881 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73420433 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71390795 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69622583 |
| 107 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.68959291 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68538146 |
| 109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.68452535 |
| 110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.68079095 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.67010974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.69727010 |
| 2 | MP0003436_decreased_susceptibility_to | 4.38204967 |
| 3 | MP0003303_peritoneal_inflammation | 3.94408791 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.50522418 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.40960861 |
| 6 | MP0002419_abnormal_innate_immunity | 3.40213619 |
| 7 | MP0009785_altered_susceptibility_to | 2.77351984 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.69911682 |
| 9 | MP0006082_CNS_inflammation | 2.60223672 |
| 10 | MP0005025_abnormal_response_to | 2.53825947 |
| 11 | MP0009278_abnormal_bone_marrow | 2.51357985 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.46741255 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.37481934 |
| 14 | MP0001533_abnormal_skeleton_physiology | 2.28065299 |
| 15 | MP0000343_altered_response_to | 2.23943044 |
| 16 | MP0009840_abnormal_foam_cell | 2.20611043 |
| 17 | MP0003724_increased_susceptibility_to | 2.18233528 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.16806307 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.14692364 |
| 20 | MP0001800_abnormal_humoral_immune | 2.12015157 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.11311536 |
| 22 | MP0001790_abnormal_immune_system | 2.10663865 |
| 23 | MP0005387_immune_system_phenotype | 2.10663865 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.06283416 |
| 25 | MP0001819_abnormal_immune_cell | 2.04537563 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.04423717 |
| 27 | MP0002723_abnormal_immune_serum | 2.03896513 |
| 28 | MP0003690_abnormal_glial_cell | 2.03294147 |
| 29 | MP0000604_amyloidosis | 1.97401290 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.92628937 |
| 31 | MP0002405_respiratory_system_inflammati | 1.90670716 |
| 32 | MP0003075_altered_response_to | 1.88230857 |
| 33 | MP0000685_abnormal_immune_system | 1.85357802 |
| 34 | MP0003448_altered_tumor_morphology | 1.77704929 |
| 35 | MP0001853_heart_inflammation | 1.75002958 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.74735674 |
| 37 | MP0002132_abnormal_respiratory_system | 1.73234651 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.71713650 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.71713650 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.70652672 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.67959823 |
| 42 | MP0000858_altered_metastatic_potential | 1.64396822 |
| 43 | MP0005451_abnormal_body_composition | 1.60735386 |
| 44 | MP0005671_abnormal_response_to | 1.58747571 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.54872060 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.52766333 |
| 47 | MP0004510_myositis | 1.50136056 |
| 48 | MP0000716_abnormal_immune_system | 1.48840806 |
| 49 | MP0008469_abnormal_protein_level | 1.47974430 |
| 50 | MP0010307_abnormal_tumor_latency | 1.46499180 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.46186395 |
| 52 | MP0002933_joint_inflammation | 1.44390383 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.44059611 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.38013126 |
| 55 | MP0002398_abnormal_bone_marrow | 1.36321070 |
| 56 | MP0001851_eye_inflammation | 1.35659469 |
| 57 | MP0009764_decreased_sensitivity_to | 1.35561247 |
| 58 | MP0004947_skin_inflammation | 1.34400980 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.33825124 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.33018341 |
| 61 | MP0003866_abnormal_defecation | 1.31288629 |
| 62 | MP0005310_abnormal_salivary_gland | 1.30461391 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.27382991 |
| 64 | MP0002429_abnormal_blood_cell | 1.25495267 |
| 65 | MP0002722_abnormal_immune_system | 1.21844833 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.20002708 |
| 67 | MP0003828_pulmonary_edema | 1.19918007 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.13821858 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.12692394 |
| 70 | MP0004883_abnormal_blood_vessel | 1.11215575 |
| 71 | MP0004381_abnormal_hair_follicle | 1.11171892 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.10988477 |
| 73 | MP0005164_abnormal_response_to | 1.07320777 |
| 74 | MP0005390_skeleton_phenotype | 1.07225810 |
| 75 | * MP0005166_decreased_susceptibility_to | 1.05100412 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.03313383 |
| 77 | MP0001958_emphysema | 1.02825995 |
| 78 | MP0002006_tumorigenesis | 0.96216105 |
| 79 | MP0003279_aneurysm | 0.95800893 |
| 80 | MP0008004_abnormal_stomach_pH | 0.95458168 |
| 81 | MP0000920_abnormal_myelination | 0.94376569 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.93330082 |
| 83 | MP0009763_increased_sensitivity_to | 0.91506096 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.90995011 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 0.90057900 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 0.89868497 |
| 87 | MP0000490_abnormal_crypts_of | 0.88612086 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.86804476 |
| 89 | MP0000249_abnormal_blood_vessel | 0.83135827 |
| 90 | MP0001873_stomach_inflammation | 0.81871171 |
| 91 | MP0008260_abnormal_autophagy | 0.81031381 |
| 92 | MP0003795_abnormal_bone_structure | 0.79440010 |
| 93 | MP0005023_abnormal_wound_healing | 0.76791592 |
| 94 | MP0003329_amyloid_beta_deposits | 0.73423910 |
| 95 | MP0001663_abnormal_digestive_system | 0.72597592 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.64385259 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.63959667 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.62865151 |
| 99 | MP0008874_decreased_physiological_sensi | 0.61591832 |
| 100 | MP0000609_abnormal_liver_physiology | 0.61002989 |
| 101 | MP0000371_diluted_coat_color | 0.60758427 |
| 102 | MP0003186_abnormal_redox_activity | 0.59708306 |
| 103 | MP0002009_preneoplasia | 0.59391923 |
| 104 | MP0003045_fibrosis | 0.59067314 |
| 105 | MP0004130_abnormal_muscle_cell | 0.58512112 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.58492864 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.58343843 |
| 108 | MP0005083_abnormal_biliary_tract | 0.57491371 |
| 109 | MP0000703_abnormal_thymus_morphology | 0.57370267 |
| 110 | MP0002090_abnormal_vision | 0.57205588 |
| 111 | MP0003091_abnormal_cell_migration | 0.57164429 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.56261667 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55874505 |
| 114 | MP0003634_abnormal_glial_cell | 0.55598953 |
| 115 | MP0000598_abnormal_liver_morphology | 0.55330709 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.54780203 |
| 117 | MP0006054_spinal_hemorrhage | 0.53649474 |
| 118 | MP0005388_respiratory_system_phenotype | 0.53069194 |
| 119 | MP0002133_abnormal_respiratory_system | 0.53069194 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.52575601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.43009054 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 6.61432541 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 6.53368426 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.22101879 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.17978140 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.10326288 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.46740386 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.42870008 |
| 9 | Dysostosis multiplex (HP:0000943) | 5.11689920 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.56896712 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.52205856 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.52205856 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.52205856 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.35185921 |
| 15 | Mucopolysacchariduria (HP:0008155) | 4.35185921 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.21573346 |
| 17 | Obstructive lung disease (HP:0006536) | 4.21573346 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.09189583 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.09189583 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.09189583 |
| 21 | Disinhibition (HP:0000734) | 4.09036280 |
| 22 | Axonal loss (HP:0003447) | 3.94346501 |
| 23 | Myositis (HP:0100614) | 3.86011245 |
| 24 | Gingivitis (HP:0000230) | 3.84747098 |
| 25 | Loss of speech (HP:0002371) | 3.80718013 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.77214901 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.76823521 |
| 28 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.74357134 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.65165306 |
| 30 | Recurrent skin infections (HP:0001581) | 3.63194482 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.60914474 |
| 32 | Agnosia (HP:0010524) | 3.47196082 |
| 33 | Amyloidosis (HP:0011034) | 3.44227781 |
| 34 | Encephalitis (HP:0002383) | 3.37960917 |
| 35 | Keratoconjunctivitis (HP:0001096) | 3.32091138 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25379537 |
| 37 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.20634244 |
| 38 | Hepatosplenomegaly (HP:0001433) | 3.19343824 |
| 39 | Orchitis (HP:0100796) | 3.13074708 |
| 40 | Glomerulonephritis (HP:0000099) | 3.11633056 |
| 41 | Thoracic kyphosis (HP:0002942) | 3.11319339 |
| 42 | J-shaped sella turcica (HP:0002680) | 3.07334045 |
| 43 | Increased IgE level (HP:0003212) | 3.00749824 |
| 44 | Recurrent fungal infections (HP:0002841) | 3.00114341 |
| 45 | Episodic fever (HP:0001954) | 2.99614562 |
| 46 | Chest pain (HP:0100749) | 2.99059761 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.89553900 |
| 48 | Abnormality of the lumbar spine (HP:0100712) | 2.88342596 |
| 49 | Urticaria (HP:0001025) | 2.87982906 |
| 50 | Upper motor neuron abnormality (HP:0002127) | 2.87742154 |
| 51 | T lymphocytopenia (HP:0005403) | 2.84848591 |
| 52 | Cellulitis (HP:0100658) | 2.81039210 |
| 53 | Periodontitis (HP:0000704) | 2.77890371 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.71188859 |
| 55 | Stomatitis (HP:0010280) | 2.70330184 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.66639440 |
| 57 | Joint hemorrhage (HP:0005261) | 2.66498516 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.57911789 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.55158543 |
| 60 | Hypochromic anemia (HP:0001931) | 2.54876835 |
| 61 | Pustule (HP:0200039) | 2.54587941 |
| 62 | Anorexia (HP:0002039) | 2.53883408 |
| 63 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.53677520 |
| 64 | Pulmonary embolism (HP:0002204) | 2.52650046 |
| 65 | Optic neuritis (HP:0100653) | 2.50189640 |
| 66 | Retrobulbar optic neuritis (HP:0100654) | 2.50189640 |
| 67 | Myocardial infarction (HP:0001658) | 2.45895615 |
| 68 | Purpura (HP:0000979) | 2.44093697 |
| 69 | Peritonitis (HP:0002586) | 2.44070449 |
| 70 | Meningitis (HP:0001287) | 2.40699277 |
| 71 | Hematochezia (HP:0002573) | 2.39654438 |
| 72 | Abnormality of the thoracic spine (HP:0100711) | 2.39341001 |
| 73 | Osteomyelitis (HP:0002754) | 2.37006935 |
| 74 | Diminished motivation (HP:0000745) | 2.36200350 |
| 75 | Pathologic fracture (HP:0002756) | 2.32252172 |
| 76 | Gangrene (HP:0100758) | 2.30913571 |
| 77 | Abnormality of complement system (HP:0005339) | 2.26895833 |
| 78 | Increased serum ferritin (HP:0003281) | 2.26580582 |
| 79 | Apathy (HP:0000741) | 2.26471485 |
| 80 | Abnormality of T cells (HP:0002843) | 2.23029707 |
| 81 | Abnormality of the pleura (HP:0002103) | 2.22058750 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.20917536 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.20304795 |
| 84 | Polyneuropathy (HP:0001271) | 2.18680305 |
| 85 | Increased IgM level (HP:0003496) | 2.17432495 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 2.16919348 |
| 87 | Global brain atrophy (HP:0002283) | 2.13020429 |
| 88 | Peripheral demyelination (HP:0011096) | 2.12597914 |
| 89 | Colitis (HP:0002583) | 2.11076033 |
| 90 | Recurrent viral infections (HP:0004429) | 2.10413560 |
| 91 | Recurrent pneumonia (HP:0006532) | 2.10070758 |
| 92 | Vertigo (HP:0002321) | 2.09297218 |
| 93 | Petechiae (HP:0000967) | 2.07744528 |
| 94 | Personality changes (HP:0000751) | 2.07414026 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 2.07186530 |
| 96 | Glomerulopathy (HP:0100820) | 2.07180197 |
| 97 | Abnormality of the endocardium (HP:0004306) | 2.06444527 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.05777103 |
| 99 | Granulocytopenia (HP:0001913) | 2.05736812 |
| 100 | Vasculitis (HP:0002633) | 2.05601045 |
| 101 | Inappropriate behavior (HP:0000719) | 2.05362587 |
| 102 | Abnormality of the peritoneum (HP:0002585) | 2.04985369 |
| 103 | Spondylolisthesis (HP:0003302) | 2.04896870 |
| 104 | Prostate neoplasm (HP:0100787) | 2.04464910 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 2.04438630 |
| 106 | Leukocytosis (HP:0001974) | 2.03056736 |
| 107 | Microcytic anemia (HP:0001935) | 2.02706575 |
| 108 | Epistaxis (HP:0000421) | 2.02535987 |
| 109 | Nephritis (HP:0000123) | 2.00075465 |
| 110 | Deformed sella turcica (HP:0002681) | 1.97512910 |
| 111 | Amaurosis fugax (HP:0100576) | 1.96757586 |
| 112 | Inflammation of the large intestine (HP:0002037) | 1.96643092 |
| 113 | Ovoid vertebral bodies (HP:0003300) | 1.96130022 |
| 114 | Complement deficiency (HP:0004431) | 1.94383201 |
| 115 | Slow saccadic eye movements (HP:0000514) | 1.93613915 |
| 116 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93306601 |
| 117 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93306601 |
| 118 | Hypergammaglobulinemia (HP:0010702) | 1.93161221 |
| 119 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93051387 |
| 120 | Premature loss of primary teeth (HP:0006323) | 1.91010731 |
| 121 | Increased CSF protein (HP:0002922) | 1.90552146 |
| 122 | Lymphopenia (HP:0001888) | 1.90302012 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 1.89907403 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.89774665 |
| 125 | Acne (HP:0001061) | 1.89503321 |
| 126 | Gingival bleeding (HP:0000225) | 1.89106113 |
| 127 | Skin ulcer (HP:0200042) | 1.87921537 |
| 128 | Chronic otitis media (HP:0000389) | 1.86072283 |
| 129 | Gastrointestinal inflammation (HP:0004386) | 1.84653592 |
| 130 | Prolonged bleeding time (HP:0003010) | 1.84210366 |
| 131 | Pulmonary infiltrates (HP:0002113) | 1.83964654 |
| 132 | Arterial thrombosis (HP:0004420) | 1.82324605 |
| 133 | Poor head control (HP:0002421) | 1.80359785 |
| 134 | Thickened calvaria (HP:0002684) | 1.79926175 |
| 135 | Neurodegeneration (HP:0002180) | 1.79178031 |
| 136 | Hemoptysis (HP:0002105) | 1.78759565 |
| 137 | Mucosal telangiectasiae (HP:0100579) | 1.74540633 |
| 138 | Sepsis (HP:0100806) | 1.74527447 |
| 139 | Abnormal platelet function (HP:0011869) | 1.74446477 |
| 140 | Impaired platelet aggregation (HP:0003540) | 1.74446477 |
| 141 | Hypercholesterolemia (HP:0003124) | 1.74105265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.84154036 |
| 2 | RIPK4 | 3.58598993 |
| 3 | IRAK4 | 3.44468894 |
| 4 | KIT | 3.29959248 |
| 5 | ERN1 | 3.19508069 |
| 6 | MAP2K3 | 2.56860276 |
| 7 | TEC | 2.49033997 |
| 8 | PRPF4B | 2.48982490 |
| 9 | TYK2 | 2.42591089 |
| 10 | BTK | 2.31143003 |
| 11 | FES | 2.30962013 |
| 12 | TAOK3 | 2.29569977 |
| 13 | TBK1 | 2.25647958 |
| 14 | TRIB3 | 2.19051501 |
| 15 | MAP4K1 | 2.15721543 |
| 16 | TNK2 | 2.10769267 |
| 17 | TGFBR2 | 1.92692040 |
| 18 | EPHB1 | 1.92483772 |
| 19 | HCK | 1.91129549 |
| 20 | CSK | 1.89837164 |
| 21 | CSF1R | 1.86408489 |
| 22 | STK10 | 1.85524930 |
| 23 | PKN2 | 1.84444844 |
| 24 | ITK | 1.74690915 |
| 25 | TRPM7 | 1.72530601 |
| 26 | ZAP70 | 1.69269947 |
| 27 | MAP3K3 | 1.60912236 |
| 28 | FGR | 1.57531893 |
| 29 | IRAK3 | 1.56776339 |
| 30 | SYK | 1.51405718 |
| 31 | GRK6 | 1.46915548 |
| 32 | TTN | 1.36553134 |
| 33 | CAMK1D | 1.32611489 |
| 34 | MAP3K14 | 1.32543409 |
| 35 | LRRK2 | 1.31389610 |
| 36 | RIPK1 | 1.27858048 |
| 37 | TESK2 | 1.27771228 |
| 38 | BMPR2 | 1.27232390 |
| 39 | SCYL2 | 1.24457524 |
| 40 | NME2 | 1.23980206 |
| 41 | LYN | 1.22671377 |
| 42 | CAMKK2 | 1.21465783 |
| 43 | CLK1 | 1.20010290 |
| 44 | SIK3 | 1.17309293 |
| 45 | PAK4 | 1.16887756 |
| 46 | JAK1 | 1.15524182 |
| 47 | JAK2 | 1.14303794 |
| 48 | MAP3K11 | 1.11701946 |
| 49 | NEK9 | 1.10666414 |
| 50 | IRAK2 | 1.04362240 |
| 51 | LCK | 1.04128861 |
| 52 | PTK6 | 1.02739455 |
| 53 | ERBB3 | 1.00133876 |
| 54 | IKBKB | 0.98351017 |
| 55 | IRAK1 | 0.94390931 |
| 56 | MARK2 | 0.94171207 |
| 57 | MATK | 0.92356585 |
| 58 | IKBKE | 0.92064724 |
| 59 | PIM2 | 0.90167192 |
| 60 | RPS6KA4 | 0.84229776 |
| 61 | CAMKK1 | 0.78973972 |
| 62 | ABL2 | 0.78281387 |
| 63 | CAMK1G | 0.77136514 |
| 64 | CDK19 | 0.76910264 |
| 65 | JAK3 | 0.76553947 |
| 66 | MARK3 | 0.76131167 |
| 67 | GRK7 | 0.75555948 |
| 68 | MAPK12 | 0.74301343 |
| 69 | MAP3K2 | 0.73303498 |
| 70 | PRKD2 | 0.73179332 |
| 71 | PIM1 | 0.71805184 |
| 72 | EGFR | 0.71139094 |
| 73 | PRKCD | 0.70966187 |
| 74 | MAPK7 | 0.70254756 |
| 75 | FLT3 | 0.70009840 |
| 76 | MAP3K13 | 0.68435021 |
| 77 | CDK12 | 0.68263791 |
| 78 | ABL1 | 0.65313194 |
| 79 | SIK2 | 0.64939941 |
| 80 | MOS | 0.62289733 |
| 81 | CDC42BPA | 0.61634776 |
| 82 | TESK1 | 0.61022387 |
| 83 | SGK3 | 0.60825062 |
| 84 | TXK | 0.60214544 |
| 85 | STK4 | 0.58237653 |
| 86 | MAP2K4 | 0.54363609 |
| 87 | MAP3K7 | 0.52892388 |
| 88 | KSR2 | 0.51370059 |
| 89 | CDK6 | 0.50622054 |
| 90 | STK11 | 0.50465716 |
| 91 | MAP3K8 | 0.49522930 |
| 92 | DAPK2 | 0.49248582 |
| 93 | DYRK1B | 0.48852904 |
| 94 | KSR1 | 0.47822241 |
| 95 | RPS6KA6 | 0.47250962 |
| 96 | PRKCQ | 0.47148548 |
| 97 | SMG1 | 0.46319001 |
| 98 | MAPKAPK2 | 0.46091494 |
| 99 | MAP3K1 | 0.45837548 |
| 100 | MAP3K6 | 0.45437038 |
| 101 | PRKG2 | 0.45237865 |
| 102 | KDR | 0.43639090 |
| 103 | PTK2B | 0.43071308 |
| 104 | RPS6KC1 | 0.42325963 |
| 105 | RPS6KL1 | 0.42325963 |
| 106 | FGFR3 | 0.41799444 |
| 107 | PIK3CG | 0.41742972 |
| 108 | * FYN | 0.41671443 |
| 109 | TAOK2 | 0.41593277 |
| 110 | RAF1 | 0.40935498 |
| 111 | PTK2 | 0.40916972 |
| 112 | SGK2 | 0.39698848 |
| 113 | PDK1 | 0.39455385 |
| 114 | PDPK1 | 0.38579156 |
| 115 | YES1 | 0.38561211 |
| 116 | RPS6KA2 | 0.37522579 |
| 117 | TAOK1 | 0.35275389 |
| 118 | HIPK2 | 0.35121506 |
| 119 | IGF1R | 0.34747647 |
| 120 | PRKCH | 0.34270219 |
| 121 | RET | 0.33353335 |
| 122 | MAP3K5 | 0.32793249 |
| 123 | MAP3K12 | 0.32739200 |
| 124 | EPHA3 | 0.29593946 |
| 125 | CAMK4 | 0.29564112 |
| 126 | MAP2K6 | 0.29099862 |
| 127 | CDK9 | 0.28438106 |
| 128 | ALK | 0.26720141 |
| 129 | MAPK4 | 0.24745556 |
| 130 | SRC | 0.24144758 |
| 131 | NEK2 | 0.24061013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.54047728 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.28411990 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.81980654 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.64616803 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.35472578 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.60265858 |
| 7 | Phagosome_Homo sapiens_hsa04145 | 2.52353033 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50584013 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.36844236 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.28053339 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.26903969 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.22626916 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18496313 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.01528125 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94704914 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.87234610 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85377804 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.83827658 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.73150879 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.72741448 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.62858174 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56707422 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.51199180 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47536723 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.45136258 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.42059649 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41349497 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39664509 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38364397 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38045353 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33825539 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30541397 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.30024086 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.26546832 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20683497 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20031940 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20018406 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15889727 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11609180 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10643816 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07850237 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.03850090 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03830902 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01266191 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01256820 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01061054 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.00347571 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94495100 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93591893 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.90254757 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87660104 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86959952 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86938488 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85839203 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85563800 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85377048 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82651418 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.81677768 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.81545301 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77828261 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.76403593 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75247326 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73353796 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73160041 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72709894 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71505470 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.66548612 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64242553 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63476716 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63393838 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61481520 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60903294 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59434120 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59336710 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57812119 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57178671 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54706285 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54398593 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52580037 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51664926 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51385194 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51210762 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50363215 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50268451 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49697787 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48814928 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48627752 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48416851 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48007084 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47849059 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47586843 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47436329 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46062223 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45713855 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44577335 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39844749 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39235423 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38195823 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37986330 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37189025 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37104995 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36333919 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36325987 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35967660 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35639700 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.34761555 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34074790 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32944229 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.31874545 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30550996 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29368412 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28946645 |
| 113 | Allograft rejection_Homo sapiens_hsa05330 | 0.27623042 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.24781913 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23879120 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22735002 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21370962 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.19526241 |
| 119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18938233 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18794692 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18748447 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.18120740 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17249696 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.16770396 |

